Download whitepaper: Inside and outside view of LatAm Biotechnology

In Clinical Trials, Drug Discovery, Manufacturing by Cristina ValdesLeave a Comment

Click here to get this paper written by Dr. Roberto de Araújo of RDO R&D

pharmaceutical markets in Latin America, particularly in Brazil, Mexico and Argentina

After 22 years of working and studying abroad, Dr Araújo shares his perspective of the biopharma industry in Latin America from both inside and outside of the region. He writes about how the insiders see international investors and what are the pros and cons for those interested in exploring LatAm biopharmaceutical markets.

Stronger democracies, decreased inflation and increased income transformed the purchasing power and capitalist mind frame of the population, which in return is empowering consumption. This combined with specific regulatory landmarks and universal health care systems have all played their part in the growing pharmaceutical markets in Latin America, particularly in Brazil, Mexico and Argentina. 

To read the full whitepaper, click here.

Dr. Roberto de Araújo will be participating in the BioPharma LatAm Convention is São Paulo, Brazil this April. For more information on this event, click here.

Leave a Comment

Current ye@r *